Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial.
Li MF, Li XL, Fan KL, Yu YY, Gong J, Geng SY, Liang YF, Huang L, Qiu JH, Tian XH, Wang WT, Zhang XL, Yu QX, Zhang YF, Lin P, Wang LN, Li X, Hou M, Liu LY, Peng J.
Li MF, et al. Among authors: yu qx, yu yy.
J Hematol Oncol. 2017 May 11;10(1):104. doi: 10.1186/s13045-017-0476-1.
J Hematol Oncol. 2017.
PMID: 28494777
Free PMC article.
Clinical Trial.